Reversible Posterior Leukoencephalopathy Syndrome Developing After Restart of Sunitinib Therapy for Metastatic Renal Cell Carcinoma

A 64-year-old Japanese man had started molecular-targeted therapy with sunitinib for lymph node metastasis 5 years after nephrectomy for left renal cell carcinoma (clear cell carcinoma, G2, pT2N0M0). He was transported to our emergency department because of generalized tonic-clonic seizure, vision l...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukui, Shinji, Toyoshima, Yuta, Inoue, Takeshi, Kagebayashi, Yoriaki, Samma, Shoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067324/
https://www.ncbi.nlm.nih.gov/pubmed/27795711
http://dx.doi.org/10.1155/2016/6852951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067324/
https://www.ncbi.nlm.nih.gov/pubmed/27795711
http://dx.doi.org/10.1155/2016/6852951

Ejemplares similares